Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2022 | 4 |
2023 | 1 |
2024 | 2 |
Search Results
6 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
METTL3 promotes intrahepatic cholangiocarcinoma progression by regulating IFIT2 expression in an m6A-YTHDF2-dependent manner.
Oncogene. 2022 Mar;41(11):1622-1633. doi: 10.1038/s41388-022-02185-1. Epub 2022 Jan 29.
Oncogene. 2022.
PMID: 35094011
Free PMC article.
YTHDF2 promotes intrahepatic cholangiocarcinoma progression and desensitises cisplatin treatment by increasing CDKN1B mRNA degradation.
Huang CS, Zhu YQ, Xu QC, Chen S, Huang Y, Zhao G, Ni X, Liu B, Zhao W, Yin XY.
Huang CS, et al.
Clin Transl Med. 2022 Jun;12(6):e848. doi: 10.1002/ctm2.848.
Clin Transl Med. 2022.
PMID: 35696608
Free PMC article.
Item in Clipboard
Imatinib facilitates gemcitabine sensitivity by targeting epigenetically activated PDGFC signaling in pancreatic cancer.
Shi YH, Xu QC, Zhu YQ, Liu ZD, Zhao GY, Liu Q, Wang XY, Wang JQ, Xu X, Su Q, Lai JM, Huang CS, Yin XY.
Shi YH, et al.
Mol Ther. 2023 Feb 1;31(2):503-516. doi: 10.1016/j.ymthe.2022.11.004. Epub 2022 Nov 15.
Mol Ther. 2023.
PMID: 36384875
Free PMC article.
Item in Clipboard
CSNK2A1 confers gemcitabine resistance to pancreatic ductal adenocarcinoma via inducing autophagy.
Liu ZD, Shi YH, Xu QC, Zhao GY, Zhu YQ, Li FX, Ma MJ, Ye JY, Huang XT, Wang XY, Xu X, Wang JQ, Zhao W, Yin XY.
Liu ZD, et al.
Cancer Lett. 2024 Mar 31;585:216640. doi: 10.1016/j.canlet.2024.216640. Epub 2024 Jan 28.
Cancer Lett. 2024.
PMID: 38290659
Free article.
Item in Clipboard
CMTM6 inhibits tumor growth and reverses chemoresistance by preventing ubiquitination of p21 in hepatocellular carcinoma.
Huang Y, Zhu Y, Yang J, Pan Q, Zhao J, Song M, Yang C, Han Y, Tang Y, Wang Q, He J, Li Y, He J, Chen H, Weng D, Xiang T, Xia JC.
Huang Y, et al. Among authors: zhu y.
Cell Death Dis. 2022 Mar 19;13(3):251. doi: 10.1038/s41419-022-04676-1.
Cell Death Dis. 2022.
PMID: 35304440
Free PMC article.
Item in Clipboard
ADAR1 promotes cisplatin resistance in intrahepatic cholangiocarcinoma by regulating BRCA2 expression through A-to-I editing manner.
Liu Q, Huang CS, Chen S, Zhu YQ, Huang XT, Zhao GY, Xu QC, Shi YH, Li W, Wang R, Yin XY.
Liu Q, et al.
Cell Prolif. 2024 May 21:e13659. doi: 10.1111/cpr.13659. Online ahead of print.
Cell Prolif. 2024.
PMID: 38773866
Item in Clipboard
Cite
Cite